ARYZTA AG (ARYN) Q2 2026 Earnings Report

The call paints a mixed picture: near-term top-line pressure and notable regional weakness in Germany drove organic decline and margin compression, but material positives include clear progress on Project Excellence, confirmed cost savings (EUR 8–10M to date), stronger capital structure (net debt down ~EUR 100M, leverage 2.7x), stable free cash flow, a high innovation rate (~19%), and strategic actions (hybrid repayment, French bolt-on acquisition, Perth ramp). Management reiterated full-year profit improvement targets while guiding to the lower end of organic growth, and they are assessing options for Germany with further clarity expected in H2. Overall, upside depends on execution of cost programs and stabilization in European demand.

The company reiterated guidance to deliver organic growth at the lower end of its 2026 range (H1 organic -2.7%), and to deliver further EBITDA and EBIT improvement for the full year with EBITDA margin expected to recover in H2 after an H1 reported margin of 13.2% (which included ~EUR 5.4m of one‑time costs, ~50bps); free cash flow was EUR 23.6m in H1 and solid full‑year cash generation is expected alongside an improvement in net debt/EBITDA (net debt ~EUR 789m, leverage 2.7x), financing costs guidance was tightened to the lower end of EUR 37–40m, interest‑rate hedges cover 29% of bank debt and expire in H2, Project Excellence targets EUR 20–30m net savings by 2028 (EUR 8–10m gross reductions confirmed to date, ~45% production coverage now, full footprint by end‑2027), rest‑of‑world EBITDA margin is expected to return to prior‑year levels, and the board will propose a capital return to shareholders in 2027 (dividend, buyback or both) as it evolves toward Swiss‑listed SME payout ratios.